Fatigue and quality of life in citrin deficiency during adaptation and compensation stage

Molecular Genetics and Metabolism

Volumn 109, Issue 1, 2013, Pages 9-13

  Okano, Yoshiyuki ^a   Kobayashi, Kyoko ^b   Ihara, Kenji ^c   Ito, Tetsuya ^d   Yoshino, Makoto ^e,f   Watanabe, Yoriko ^f   Kaji, Shunsaku ^g   Ohura, Toshihiro ^h   Nagao, Masayoshi ⁱ   Noguchi, Atsuko ^j   Mushiake, Sotaro ^k   Hohashi, Naohiro ^l   Hashimoto Tamaoki, Tomoko ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^e Division of Gene Therapy and Regenerative Medicine   (Japan)

^f KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g Tsuyama Central Hospital   (Japan)

^h TOHOKU UNIVERSITY HOSPITAL   (Japan)

ⁱ HOKKAIDO MEDICAL CENTER   (Japan)

^j AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l KOBE UNIVERSITY   (Japan)

more..

Author keywords

Aspartate glutamate carrier; Citrin; Citrullinemia; Fatigue; Mitochondria; QOL

Indexed keywords

ADAPTATION; ADOLESCENT; ADULT; ARTICLE; CHILD; CITRIN DEFICIENCY; CITRULLINEMIA TYPE II; CONTROLLED STUDY; CORRELATION ANALYSIS; CUSTODY; FATIGUE; FEMALE; GENERIC CORE SCALES; HUMAN; MAJOR CLINICAL STUDY; MALE; PEDSQL MULTIDIMENSIONAL FATIGUE SCALE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCHOOL CHILD; UREA CYCLE DISORDER;

ADAPTATION, PHYSIOLOGICAL; ADOLESCENT; CALCIUM-BINDING PROTEINS; CARBOHYDRATE METABOLISM; CHILD; CHILD, PRESCHOOL; CITRULLINEMIA; DIET, HIGH-FAT; FATIGUE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; ORGANIC ANION TRANSPORTERS; QUALITY OF LIFE; YOUNG ADULT;

EID: 84876077224     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.01.020     Document Type: Article

References (41)

1. Kobayashi K., Sinasac D.S., Iijima M., Boright A.P., Begum L., Lee J.R., Yasuda T., Ikeda S., Hirano R., Terazono H., Crackower M.A., Kondo I., Tsui L.C., Scherer S.W., Saheki T. The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat. Genet. 1999, 22:159-163.
2. Palmieri L., Pardo B., Lasorsa F.M., del Arco A., Kobayashi K., Iijima M., Runswick M.J., Walker J.E., Saheki T., Satrustegui J., Palmieri F. Citrin and aralar1 are Ca(2+) stimulated aspartate/glutamate transporters in mitochondria. EMBO J. 2001, 20:5060-5069.
3. Palmieri F. Diseases caused by defects of mitochondrial carriers. Biochim. Biophys. Acta 2008, 1777:564-578.
4. Saheki T., Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J. Hum. Genet. 2002, 47:333-341.
5. Yamaguchi N., Kobayashi K., Yasuda T., Nishi I., Iijima M., Nakagawa M., Osame M., Kondo I., Saheki T. Screening of SLC25A13 mutations in early and late onset patients with citrin deficiency and in the Japanese population: identification of two novel mutations and establishment of multiple DNA diagnosis method for nine mutations. Hum. Mutat. 2002, 19:122-130.
6. Kobayashi K., Shaheen N., Kumashiro R., Tanikawa K., O'Brien W.E., Beaudet A.L., Saheki T. A search for the primary abnormality in adult-onset type II citrullinemia. Am. J. Hum. Genet. 1993, 53:1024-1030.
7. Kobayashi K., Bang Lu Y., Xian Li M., Nishi I., Hsiao K.J., Choeh K., Yang Y., Hwu W.L., Reichardt J.K., Palmieri F., Okano Y., Saheki T. Screening of nine SLC25A13 mutations: their frequency in patients with citrin deficiency and high carrier rates in Asian populations. Mol. Genet. Metab. 2003, 80:356-359.
8. Kobayashi K., Iijima M., Yasuda T., Sinasac D.S., Yamaguchi N., Tsui L.C., Scherer S.W., Saheki T. Type II citrullinemia (citrin deficiency): a mysterious disease caused by a defect of calcium-binding mitochondrial carrier protein. Calcium: The Molecular Basis of Calcium Action in Biology and Medicine 2000, 565-587. Kluwer Academic Publishers, New York. R. Pochet, R. Donato, J. Haiech, C. Heizmann, V. Gerke (Eds.).
9. Saheki T., Kobayashi K., Miura T., Hashimoto S., Ueno Y., Yamasaki T., Araki H., Nara H., Shiozaki Y., Sameshima Y., Suzuki M., Yamauchi Y., Sakazume Y., Akiyama K., Yamamura Y. Serum amino acid pattern of type II citrullinemic patients and effect of oral administration of citrulline. J. Clin. Biochem. Nutr. 1986, 1:129-142.
10. Ohura T., Kobayashi K., Tazawa Y., Nishi I., Abukawa D., Sakamoto O., Iinuma K., Saheki T. Neonatal presentation of adult-onset type II citrullinemia. Hum. Genet. 2001, 108:87-90.
11. Tazawa Y., Kobayashi K., Ohura T., Abukawa D., Nishinomiya F., Hosoda Y., Yamashita M., Nagata I., Kono Y., Yasuda T., Yamaguchi N., Saheki T. Infantile cholestatic jaundice associated with adult-onset type II citrullinemia. J. Pediatr. 2001, 138:735-740.
12. Tomomasa T., Kobayashi K., Kaneko H., Shimura H., Fukusato T., Tabata N., Inoue Y., Ohwada S., Kasahara M., Morishita Y., Kimura M., Saheki T., Morikawa A. Possible clinical and histological manifestations of adult-onset type II citrullinemia in early infancy. J. Pediatr. 2001, 138:741-743.
13. Tamamori A., Okano Y., Ozaki H., Fujimoto A., Kajiwara M., Fukuda K., Kobayashi K., Saheki T., Tagami Y., Yamano T. Neonatal intrahepatic cholestasis caused by citrin deficiency: severe hepatic dysfunction in an infant requiring liver transplantation. Eur. J. Pediatr. 2002, 161:609-613.
14. Tamamori A., Fujimoto A., Okano Y., Kobayashi K., Saheki T., Tagami Y., Takei H., Shigematsu Y., Hata I., Ozaki H., Tokuhara D., Nishimura Y., Yorifuji T., Igarashi N., Ohura T., Shimizu T., Inui K., Sakai N., Abukawa D., Miyakawa T., Matsumori M., Ban K., Kaneko H., Yamano T. Effects of citrin deficiency in the perinatal period: feasibility of newborn mass screening for citrin deficiency. Pediatr. Res. 2004, 56:608-614.
15. Ohura T., Kobayashi K., Tazawa Y., Abukawa D., Sakamoto O., Tsuchiya S., Saheki T. Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). J. Inherit. Metab. Dis. 2007, 30:139-144.
16. Shigeta T., Kasahara M., Kimura T., Fukuda A., Sasaki K., Arai K., Nakagawa A., Nakagawa S., Kobayashi K., Soneda S., Kitagawa H. Liver transplantation for an infant with neonatal intrahepatic cholestasis caused by citrin deficiency using heterozygote living donor. Pediatr. Transplant. 2010, 14:E86-E88.
17. Saheki T., Kobayashi K., Terashi M., Ohura T., Yanagawa Y., Okano Y., Hattori T., Fujimoto H., Mutoh K., Kizaki Z., Inui A. Reduced carbohydrate intake in citrin-deficient subjects. J. Inherit. Metab. Dis. 2008, 31:386-394.
18. Nagasaka H., Okano Y., Tsukahara H., Shigematsu Y., Momoi T., Yorifuji J., Miida T., Ohura T., Kobayashi K., Saheki T., Hirano K., Takayanagi M., Yorifuji T. Sustaining hypercitrullinemia, hypercholesterolemia and augmented oxidative stress in Japanese children with aspartate/glutamate carrier isoform 2-citrin-deficiency even during the silent period. Mol. Genet. Metab. 2009, 97:21-26.
19. Varni J.W., Seid M., Rode C.A. The PedsQL™: measurement model for the pediatric quality of life inventory. Med. Care 1999, 37:126-139.
20. Varni J.W., Seid M., Kurtin P.S. PedsQL™ 4.0: reliability and validity of the Pediatric Quality of Life Inventory™ version 4.0 generic core scales in healthy and patient populations. Med. Care 2001, 39:800-812.
21. Kobayashi K., Kamibeppu K. Measuring quality of life in Japanese children: development of the Japanese version of PedsQL™. Pediatr. Int. 2010, 52:80-88.
22. Kobayashi K., Okano Y., Hohashi N. Reliability and validity of the PedsQL™ Multidimensional Fatigue Scale in Japan. Qual. Life Res. 2011, 20:1091-1102.
23. Swain M.G. Fatigue in chronic disease. Clin. Sci. 2000, 99:1-8.
24. Bakker R.J., van de Putte E.M., Kuis W., Sinnema G. Risk factors for persistent fatigue with significant school absence in children and adolescents. Pediatrics 2009, 124:e89-e95.
25. Sankey A., Hill C.M., Brown J., Quinn L., Fletcher A. A follow-up study of chronic fatigue syndrome in children and adolescents: symptom persistence and school absenteeism. Clin. Child. Psychol. Psychiatry 2006, 11:126-138.
26. McHorney C.A., Ware J.E., Lu J.F., Sherbourne C.D. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med. Care 1994, 32:40-66.
27. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum Associates, Hillsdale. 2nd ed.
28. McGraw K.O., Wong S.P. Forming inferences about some intraclass correlation coefficients. Psychol. Methods 1996, 1:30-46.
29. Shrout P.E. Measurement reliability and agreement in psychiatry. Stat. Methods Med. Res. 1998, 7:301-317.
30. Wilson K.A., Dowling A.J., Abdolell M., Tannock I.F. Perception of quality of life by patients, partners and treating physicians. Qual. Life Res. 2000, 9:1041-1052.
31. Sneeuw K.C., Aaronson N.K., Sprangers M.A., Detmar S.B., Wever L.D., Schornagel J.H. Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients. J. Clin. Epidemiol. 1998, 51:617-631.
32. Varni J.W., Limbers C.A., Bryant W.P., Wilson D.P. The PedsQL Multidimensional Fatigue Scale in type 1 diabetes: feasibility, reliability, and validity. Pediatr. Diabetes 2009, 10:321-328.
33. Varni J.W., Burwinkle T.M., Szer I.S. The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity. J. Rheumatol. 2004, 31:2494-2500.
34. Varni J.W., Burwinkle T.M., Katz E.R., Meeske K., Dickinson P. The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 2002, 94:2090-2106.
35. Varni J.W., Limbers C.A., Bryant W.P., Wilson D.P. The PedsQL Multidimensional Fatigue Scale in pediatric obesity: feasibility, reliability and validity. Int. J. Pediatr. Obes. 2010, 5:34-42.
36. Palmer S.N., Meeske K.A., Katz E.R., Burwinkle T.M., Varni J.W. The PedsQL Brain Tumor Module: initial reliability and validity. Pediatr. Blood Cancer. 2007, 49:287-293.
37. Norheim K.B., Jonsson G., Omdal R. Biological mechanisms of chronic fatigue. Rheumatology 2011, 50:1009-1018.
38. Nicolson G.L. Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function. J. Cell. Biochem. 2007, 100:1352-1369.
39. Janicke D.M., Finney J.W., Riley A.W. Children's health care use: a prospective investigation of factors related to care-seeking. Med. Care 2001, 39:990-1001.
40. Saheki T., Inoue K., Tushima A., Mutoh K., Kobayashi K. Citrin deficiency and current treatment concepts. Mol. Genet. Metab. 2010, 100(Suppl. 1):S59-S64.
41. Mutoh K., Kurokawa K., Kobayashi K., Saheki T. Treatment of a citrin-deficient patient at the early stage of adult-onset type II citrullinaemia with arginine and sodium pyruvate. J. Inherit. Metab. Dis. 2008, 31(Suppl. 2):S343-S347.